Direct comparison of mRNA expression levels for those markers plus the AML transcription factors TFE3 and FIGF (Fig. 3f) confirmed a similar expression profile for TSC2−/− organoids and kidney AML, compared to isogenic control organoids and to normal kidneys, respectively (Fig. 3f). The gene discussed is TSC2; the disease is acute myeloid leukemia.